159 related articles for article (PubMed ID: 3447533)
1. Bacteriophage treatment of suppurative skin infections.
Cisło M; Dabrowski M; Weber-Dabrowska B; Woytoń A
Arch Immunol Ther Exp (Warsz); 1987; 35(2):175-83. PubMed ID: 3447533
[TBL] [Abstract][Full Text] [Related]
2. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results.
Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R
Arch Immunol Ther Exp (Warsz); 1983; 31(3):293-327. PubMed ID: 6651485
[TBL] [Abstract][Full Text] [Related]
3. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases.
Slopek S; Durlakowa I; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
Arch Immunol Ther Exp (Warsz); 1984; 32(3):317-35. PubMed ID: 6395825
[TBL] [Abstract][Full Text] [Related]
4. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases.
Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
Arch Immunol Ther Exp (Warsz); 1985; 33(2):219-40. PubMed ID: 2935115
[TBL] [Abstract][Full Text] [Related]
5. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children.
Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
Arch Immunol Ther Exp (Warsz); 1985; 33(2):241-59. PubMed ID: 2935116
[TBL] [Abstract][Full Text] [Related]
6. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986.
Slopek S; Weber-Dabrowska B; Dabrowski M; Kucharewicz-Krukowska A
Arch Immunol Ther Exp (Warsz); 1987; 35(5):569-83. PubMed ID: 3455647
[TBL] [Abstract][Full Text] [Related]
7. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results.
Slopek S; Durlakowa I; Weber-Dabrowska B; Kucharewicz-Krukowska A; Dabrowski M; Bisikiewicz R
Arch Immunol Ther Exp (Warsz); 1983; 31(3):267-91. PubMed ID: 6651484
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of suppurative-necrotic processes in the controlled germ-free environment with drug aerosols].
Lutsevich EV; Lychkovskiĭ RM
Khirurgiia (Mosk); 1990 Sep; (9):130-2. PubMed ID: 2273823
[No Abstract] [Full Text] [Related]
9. Immunogenic effect of bacteriophage in patients subjected to phage therapy.
Kucharewicz-Krukowska A; Slopek S
Arch Immunol Ther Exp (Warsz); 1987; 35(5):553-61. PubMed ID: 3455646
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophage therapy of bacterial infections: an update of our institute's experience.
Weber-Dabrowska B; Mulczyk M; Górski A
Arch Immunol Ther Exp (Warsz); 2000; 48(6):547-51. PubMed ID: 11197610
[TBL] [Abstract][Full Text] [Related]
11. [Experience using autovaccines in the treatment of chronic suppurative diseases].
Trop IE
Klin Med (Mosk); 1989 Feb; 67(2):112-4. PubMed ID: 2657208
[No Abstract] [Full Text] [Related]
12. Studies on bacteriophage penetration in patients subjected to phage therapy.
Weber-Dabrowska B; Dabrowski M; Slopek S
Arch Immunol Ther Exp (Warsz); 1987; 35(5):563-8. PubMed ID: 3332066
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of suppurative and septic diseases in children using ultrasonic cavitation].
Ismaĭlov AA; Kuliev RA
Vestn Khir Im I I Grek; 1985 Oct; 135(10):96-8. PubMed ID: 4090201
[TBL] [Abstract][Full Text] [Related]
14. The impact of noncontact, nonthermal, low-frequency ultrasound on bacterial counts in experimental and chronic wounds.
Serena T; Lee SK; Lam K; Attar P; Meneses P; Ennis W
Ostomy Wound Manage; 2009 Jan; 55(1):22-30. PubMed ID: 19174586
[TBL] [Abstract][Full Text] [Related]
15. [Complex treatment of suppurative wounds using ultraviolet irradiation of the blood].
Shaposhnikov IuG; Rudakov BIa; Berchenko GN; Berchenko VV; Kesian GA
Khirurgiia (Mosk); 1988 Apr; (4):17-21. PubMed ID: 3398408
[No Abstract] [Full Text] [Related]
16. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections.
Slopek S; Kucharewicz-Krukowska A; Weber-Dabrowska B; Dabrowski M
Arch Immunol Ther Exp (Warsz); 1985; 33(2):261-73. PubMed ID: 2935117
[TBL] [Abstract][Full Text] [Related]
17. [New perspectives of the phage therapy].
Eyer L; Pantůcek R; Růzicková V; Doskar J
Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
[TBL] [Abstract][Full Text] [Related]
18. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and animal experiment studies on the influencing of microbial dermatosses by peloids].
Pöhler H; Schönborn C
Z Physiother; 1971; 23(5):369-76. PubMed ID: 5168992
[No Abstract] [Full Text] [Related]
20. Bacterial agents causing chronic suppurative otitis media.
Obi CL; Enweani IB; Giwa JO
East Afr Med J; 1995 Jun; 72(6):370-2. PubMed ID: 7498006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]